|
Title
|
|
|
|
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
BMC cancer. - London
| |
|
Publication
|
|
|
|
London
:
2006
| |
|
ISSN
|
|
|
|
1471-2407
| |
|
DOI
|
|
|
|
10.1186/1471-2407-6-285
| |
|
Volume/pages
|
|
|
|
6
(2006)
, p. 1-12
| |
|
ISI
|
|
|
|
000243435300001
| |
|
Note
|
|
|
|
ARTN 285
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (open access)
|
|
|
|
| |
|